CF PharmTech is a fully integrated specialty pharmaceutical company engaged in the R&D, manufacturing and commercialization of orally inhaled and nasal drug products (OINDP) for the global market. We are dedicated to building a comprehensive and integrated R&D and manufacturing platform for partners and offering CRO/CDMO services for inhalation products, including but not limited to dry powder, pMDI, nebulized solution and suspension, and nasal spray.
CF PharmTech is headquartered in Suzhou, Jiangsu Province, China, with branches established in Wuxi and overseas. It is a company full of creativity and drive. We have experienced and professional teams, advanced technology and equipment to provide full support from drug development to manufacturing for our clients. Our commitment is to provide excellent technical services that meet the highest industry standards and regulatory requirements.
CF PharmTech
No. 16 Hucundang Road
Xiangcheng District
Suzhou 215143
P.R. China
+86-510-85192705
www.cfpharmtech.com/en/
bd@cfpharmtech.com
Analytical Service for Generic and New Inhalation Drug Products
We have built an analysis laboratory in Wuxi Free Trade Zone that is in compliance with FDA and EMA requirements in 2023. Our analytical services are designed to support the client throughout all stages of inhalation product development, from early research to clinical trials and product commercialization. Our services include:
- Analytical method development/validation
- Release testing
- Stability study
- In vitro study
- Product characterization study
Formulation Development
We provide fully customizable solutions to address the client's formulation development needs in various inhalation projects (e.g., pMDI, DPI, inhalation solution and suspension, nasal sprays). Our services include:
- Pre-formulation studies
- Formulation screening
- Packaging material/device screening
- Process development
- Compatibility study
Manufacturing & Products
Our facility is equipped with advanced production lines designed for manufacturing various forms of inhalation products, including pMDIs, dry powders, inhalation solution and suspension s,and nasal sprays.
Our advanced quality system complies with the regulatory requirements of China, and escorts the production of inhalation products in the global market.
Our key commercialized products include:
- Budesonide inhalation suspension
- Azelastine Hydrochloride and Fluticasone Propionate nasal spray
Registration Service
CF Pharmtech will partner with you to provide comprehensive registration services based on our services provided. We have so far supported at least 10 drug projects to obtain IND approval and enter clinical study. We have a team of experienced regulatory experts who are familiar with the latest regulations and guidelines in various countries and regions, including the US, EU, China, and other emerging markets.
